Deutsche Bank
ESMC

Deutsche Bank’s Escalon Medical Corp ESMC Stock Holding History

Deutsche Bank’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-252
Closed – – 5492
2015
Q2 		$0 Buy
+252
New +$350 ﹤0.01% 5578
2014
Q1 		– Sell
-1
Closed – – 5930
2013
Q4 		$0 Buy
+1
New +$2 ﹤0.01% 5905

Other funds holding ESMC

YU
Yale University New Haven, Connecticut $2.05M AUM 1.81% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Deutsche Bank's ESMC Position: Q3 2015 in Review

Deutsche Bank sold out of Escalon Medical Corp (ESMC) in Q3 2015, closing a stake of 252 shares.

Deutsche Bank first reported a position in ESMC in Q4 2013 and held it in 2 quarters. The position peaked at $0 in Q2 2015. 15 funds tracked by Wall St. Rank hold ESMC as of Q3 2015.

  • Deutsche Bank reported no remaining Escalon Medical Corp position as of Q3 2015 after selling out during the quarter.
  • Deutsche Bank sold 252 Escalon Medical Corp shares in Q3 2015.
  • Deutsche Bank first reported a position in Escalon Medical Corp in Q4 2013 and held it in 2 quarters.
  • Deutsche Bank's Escalon Medical Corp position peaked at $0 in Q2 2015.
  • 15 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q3 2015.

Based on Deutsche Bank's 13F filing for Q3 2015, filed 17 Nov 2015.